ORIGINAL RESEARCH article
Front. Reprod. Health
Sec. Menopause
Volume 7 - 2025 | doi: 10.3389/frph.2025.1670141
This article is part of the Research TopicImpact of Diminished Gonadal Function on Metabolic and Cardiovascular HealthView all articles
Precision Prediction of Hyperhomocysteinemia Development in Perimenopausal Women Using LASSO Regression
Provisionally accepted- 1Hunan Provincial People's Hospital, Changsha, China
- 2Hunan Normal University, Changsha, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Hyperhomocysteinemia (HHcy) is associated with an increased risk of cardiovascular diseases, particularly in perimenopausal women, who are more susceptible to metabolic disorders due to declining estrogen levels. This study aimed to identify risk factors and develop a predictive model for HHcy in this population. Methods: A retrospective study included 687 perimenopausal women, divided into a training set (481) and an internal validation set (206). Demographic characteristics, pregnancy-related factors, lifestyles, and diet information were collected by questionnaire. 63 perimenopausal women hospitalized from March to June 2025 were selected as the external validation set. The least absolute shrinkage and selection operator (LASSO) regression was used to select variables. The logistic regression model was developed to predict HHcy risk, with results visualized using a nomogram. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Results: 137 of 687 (19.94%) perimenopausal women had HHcy. Through Lasso regression and multifactor logistic regression, 4 predictors were identified, including egg consumption frequency, LDL, TP, and CysC for constructing the nomogram model. The AUC of the training set was 0.765 (95% CI= 0.708–0.822), for the internal validation set was 0.854 (95% CI= 0.781–0.928), and for the external validation set was 0.776 (95% CI= 0.603–0.949), indicating good predictive performance of the model. Conclusion: The nomogram demonstrated high predictive accuracy and clinical utility, providing a potential tool for HHcy risk prediction and selection of treatment strategies in perimenopausal women.
Keywords: Hyperhomocysteinemia, LASSO, nomogram, Perimenopausal women, factor associated
Received: 23 Jul 2025; Accepted: 24 Sep 2025.
Copyright: © 2025 Tan, Li, Wang, Peng, Zhu, Jiang, Li and Hong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ling Li, lilingmpd@hunnu.edu.cn
Xiuqin Hong, xiuqinhong0528@hunnu.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.